Nedocromil Sodium (Akorn, Inc.)


Welcome to the PulseAid listing for the Nedocromil Sodium drug offered from Akorn, Inc.. This Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Akorn, Inc.
NON-PROPRIETARY NAME: Nedocromil Sodium
SUBSTANCE NAME: NEDOCROMIL SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC]
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2012-09-10
END MARKETING DATE: 0000-00-00


Nedocromil Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNedocromil Sodium from Akorn, Inc.
LABELER NAME: Akorn, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/mL)
START MARKETING DATE: 2012-09-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17478-066_9496f818-72c7-400f-a6ee-77c851f0d320
PRODUCT NDC: 17478-066
APPLICATION NUMBER: ANDA090638

Other NEDOCROMIL SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Nedocromil Sodium
Allergan, Inc.ALOCRIL